http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2722716-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e287a387b0d83fc22876d8857582a78 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate | 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_130e0b7c8c2b8b6aa112157f17655ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04f55b34ba1e3091b754194ccdf678e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff354de59a8e2ed1c9bd95d567ee0d17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6a8a6757fff5f863959ea542a733a2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7cfba26797844fc48249433159452d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a406c7008276c498ba863d4facb12237 |
| publicationDate | 2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2722716-C1 |
| titleOfInvention | Method of combined treatment of children with catarrhal complications of lower respiratory tract |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to pediatrics, and can be used in combined treatment of children with catarrhal complications of lower respiratory tract. That is ensured by injecting Ingaron 100000ME in an aerosol with a background of the basic drug therapy, daily once day for 7 days. At the larynx, trachea and major bronchi diseases, at laryngitis, laryngotracheitis, laryngotraheobronchitis, bronchitis; inhalations of medium-degree aerosol of 6–10 mcm are prescribed, if deep sections of the lungs – alveoli and small bronchi are affected, inhalations of fine dispersity aerosols 2.5–5 mcm are prescribed. That is followed by physiotherapy with narrow-band optical radiation (NOR) at wave length 470 nm with a Spektr LC-02 LED apparatus on a subclavian projection, interscapular and inguinal areas of the patient in continuous mode – 4 minutes per each area, holding the source above the skin with total intensity of radiation – 25–75 %, radiation power – 15–20 mW, radiation power density – 2.5–3 mW/cm.EFFECT: method enables reducing the length of the therapy by increasing the phagocytic activity of polymorphonuclear leukocytes while minimizing the drug load.1 cl, 4 dwg, 3 ex |
| priorityDate | 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.